Khosla led a $47m Series A round in Somite AI.

Khosla, a venture capital firm, led a $47m Series A round in Somite AI, a TechBio company, with participation from SciFi VC, the Chan Zuckerberg Initiative, Fusion Fund, Ajinomoto Group Ventures, Pitango HealthTech, TechAviv, Harpoon Ventures, Dr. R. Martin Chavez and Fidji Simo. "Traditional cell therapies are expensive, slow to develop, and unpredictable. AI can systematically solve these challenges. Somite AI's foundation models, once fully developed and validated, will not only create value for their own pipeline, but have the potential to reshape the entire field of human cell therapy," Vinod Khosla, Khosla Ventures Founder.